Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2002
Materias:
Virology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC120267/
https://ncbi.nlm.nih.gov/pubmed/11880402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.3.837-845.2002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares